Degradation and inactivation of antitumor drugs
- 作者John A. Benvenuto; Thomas H. Connor; David K. Monteith; Jana L. Laidlaw; Stephen C. Adams; Thomas S. Matney; Jeffrey C. Theiss
- 卷第82卷
- 期第10期
- 印刷ISSN0022-3549
- 电子ISSN1520-6017
- 文件大小529.99KB
- 发表时间1993
- DOI10.1002/jps.2600821003
- 页码988-991
Intestinal permeation enhancersBruce J. Aungst · 2000
Intranasal absorption of oxymorphoneMunir A. Hussain; Bruce J. Aungst · 1997
Absorption Enhancers: Applications and AdvancesBruce J. Aungst · 2012
Synthesis of water soluble prodrug of DMP323Prabhakar K. Jadhav; Francis J. Woerner; Bruce J. Aungst · 1996
Prodrugs for Improved Oral β-Estradiol BioavailabilityMunir A. Hussain; Bruce J. Aungst; Eli Shefter · 1988
Buccal and oral bioavailability of nalbuphine in ratsMunir A. Hussain; Bruce J. Aungst; Eli Shefter · 1986
Enhancement of the intestinal absorption of peptides and nonpeptidesBruce J. Aungst; Hiroshi Saitoh; Deborah L. Burcham; Shiew-Mei Huang; Shaker A. Mousa; Munir A. Hussain · 1996
Improved Buccal Delivery of Opioid Analgesics and Antagonists with Bitterless ProdrugsMunir A. Hussain; Bruce J. Aungst; Christopher A. Koval; Eli Shefter · 1988